Skip to main content
SpringerLink
Log in

The efficacy of intravesical BCG in the treatment of patients with high risk superficial bladder cancer

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Sixty-two patients with superficial bladder cancer stage T1 with or without dysplasia or carcinoma in situ and 34 patients with stage TA associated with dysplasia or carcinoma in situ were treated by TUR and TUR+BCG, respectively, and were followed up for an average of 46 months (6–192) and 32 months (6–72), respectively, after therapy. The recurrence rate (61%), progression (37%) and tumour death (19%) were unfavourably high in the group of patients treated by TUR only. On the contrary, the effect of intravesical BCG therapy was excellent. Recurrence rate was as low as 20.5%, and progression and tumour death were not detected in any patient. Intravesical BCG seems to be the best choice for treatment of high risk superficial bladder cancer. The authors recommend their effective modified treatment schedules.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Chapter © 2016

References

  1. Abel, P. D., Hall, R. R., Williams, G.: Should pT1 TCC of bladder still be classified as a superficial.Br. J. Urol., 62, 103 (1988).

    PubMed  CAS  Google Scholar 

  2. Adolphs, H. D., Bastian, H. P.: Chemoimmunoprophylaxis of superficial bladder tumors.J. Urol., 129, 29 (1983).

    PubMed  CAS  Google Scholar 

  3. Baccon-Gibod, L. B., Lelev, I. M., Herve, I. M., Belas, M., Steg, A.: Bladder tumours invading the lamina propria (State: T1): Influence of endovesical BCG therapy on recurrence. In: EORTC Genitourinary Group Monograph 6. Alan R. Liss, Inc., New York 1989, p. 161.

    Google Scholar 

  4. Brosman, S.: The influence of Tice Strain BCG treatment in patients with transitional cell carcinoma in situ. In: EORTC Genitourinary Group Monograph 6. Alan R. Liss, Inc., New York, 1989, p. 193.

    Google Scholar 

  5. England, H. R., Paris, A. M., Blandy, J. B.: The correlation of T1 bladder tumour history with prognosis and follow up requirements.Br. J. Urol., 53, 593 (1981).

    PubMed  CAS  Google Scholar 

  6. Giesbergs, A. G. M., van Helsdingen, I. R. O., Kramer, A. I. L.: Recurrence of superficial bladder carcinoma after intravesical instillation of Mitomycin-C.Br. J. Urol., 63, 176 (1989).

    Google Scholar 

  7. Guinan, P., Crispen, R., Rubinstein, M.: BCG in management of superficial bladder cancer.Urology, 30, 515 (1987).

    Article  PubMed  CAS  Google Scholar 

  8. Heney, N. M., Nocks, I. I., Daly, G. R., Prout, I. R., Newall, J. B., Griffin, P. P., Perrone, T. L., Szyfelbin, W. A.: TA and T1 bladder cancer: Location, recurrence and progression.Br. J. Urol., 54, 152 (1982).

    PubMed  CAS  Google Scholar 

  9. Herr, H. W., Lavdone, V. P., Badalment, P. A., Freedman, B. D., Whitmore, W. F.: BCG therapy alters progression of superficial bladder cancer. Part 2.J. Urol., 139, 299A (1988).

    Google Scholar 

  10. Jakse, G., Loidl, W., Seeber, G., Hofstadter, F.: Stage T1, grade 3 transitional cell carcinoma of bladder: An unfavorable tumor?J. Urol., 137, 39 (1987).

    PubMed  CAS  Google Scholar 

  11. Jauhianen, K., Alfthan, O.: Instillation of Mitomycin-C and Doxorubicin in the prevention of recurrent superficial (TA-T1) bladder cancer.Br. J. Urol., 60, 54 (1987).

    Google Scholar 

  12. Khanna, O. M. P., Son, D. L., Mazer, H., Read, J., Nugent, D., Cattone, R., Heeg, M., Rezvan, M., Viek, N., Friedmann, M.: Superficial bladder cancer treated by intravesical BCG or Adriamycin.J. Urol., 30, 520 (1987).

    Article  CAS  Google Scholar 

  13. Koss, L. G.: Diagnostic value of cytology of voided urine.Acta Cytol., 27, 910 (1985).

    Google Scholar 

  14. Malmström, P., Busch, Ch., Norlén, B. J.: Recurrence, progression and survival in bladder cancer.Scand. J. Urol. Nephrol., 210, 185 (1987).

    Article  Google Scholar 

  15. Martinez-Pineiro, J. A., Leon, J. J., Martinez-Pineiro, L., Fiter, L., Mosterio, J. A. Navarro, J., Garcia Matres, M. J., Carcamo, P.: BCG versus doxorubicin versus Thiotepa: a randomized prospective study.J. Urol., 143, 502 (1990).

    PubMed  CAS  Google Scholar 

  16. Morales, A. D., Eidinger, A., Bruce, W.: Intracavitary BCG in the treatment of superficial bladder tumors.J. Urol., 116, 180 (1976).

    PubMed  CAS  Google Scholar 

  17. Pasandro, V., De Paula, F.: Intravesical BCG in the treatment of superficial TCC of the bladder.J. Urol., 138, 299 (1987).

    Google Scholar 

  18. Reitsma, D. J., Guinan, P., Lamm, D. L., Khanna, O. P., Brosman, S. A., DeKernion, J. B., Williams, R. D., Simpson, G., Hanna, M. G.: Long-term effect of intravesical BCG Tise Strain on flat carcinoma in situ of the bladder. In: EORTC Genitourinary Group Monograph 6. Alan R. Liss, Inc., New York 1989, p. 171.

    Google Scholar 

  19. Rübben, H., Lutzeyer, W., Fischer, N., Deutz, F., Lagrange, W., Giani, G.: Natural history and treatment of low and high risk superficial bladder tumors.J. Urol., 139, 283 (1988).

    PubMed  Google Scholar 

  20. Sarosdy, M. F., Lamm, D. L.: Long term results of intravesical BCG therapy for superficial bladder cancer.J. Urol., 142, 719 (1989).

    PubMed  CAS  Google Scholar 

  21. Schade, R. O. K., Swinney, I.: The association of urothelial abnormalities with neoplasia: A 10-year followup.J. Urol., 129, 1125 (1983).

    PubMed  CAS  Google Scholar 

  22. Smith, G., Elton, R. A., Chisholm, G. D., Newsam, J. E., Hargreave, T. B.: Superifical bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases.Br. J. Urol., 58, 659 (1986).

    Article  PubMed  CAS  Google Scholar 

  23. Soloway, M. S., Perry, A.: BCG for treatment of superficial TCC of bladder in patients who have failed thiotepa and/or mitomycin-C.J. Urol., 137, 871 (1987).

    PubMed  CAS  Google Scholar 

  24. Stanisic, T. H., Donovan, J. M., Lebouton, J., Graham, A. R.: 5-year experience with intravesical therapy of carcinoma in situ: An inquiry into risk of “conservative” management.J. Urol., 138, 1158 (1987).

    PubMed  CAS  Google Scholar 

  25. Steg, A., Belas, M., Lelev, Ch., Baccon-Gibod, L.: Intravesical BCG therapy in patients with superficial bladder tumors. In: EORTC Genitourinary Group Monograph 6. Alan R. Liss, Inc., New York 1989, p. 153.

    Google Scholar 

  26. Stricker, P. D., Grant, A. B. F., Hasken, B. M., Taylor, I. S.: Topical mitomycin-C therapy for carcinoma in situ of bladder: A follow up.J. Urol., 143, 34 (1990).

    PubMed  CAS  Google Scholar 

  27. Wolf, H., Hojgaard, K.: Urothelial dysplasia concomitant with bladder tumours as a determinant factor for future new occurrences.Lancet, 134 (1983).

  28. Zincke, H., Utz, D. C., Farrow, G. M.: Review of Mayo Clinic experience with carcinoma in situ.Urology,26, Suppl. 39 (1985).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Jósa András Hospital, Nyíregyháza, Hungary

    L. Samodai, L. Kiss, Z. Kolozsy & L. Mohácsi

Authors
  1. L. Samodai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Kiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Z. Kolozsy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Mohácsi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Samodai, L., Kiss, L., Kolozsy, Z. et al. The efficacy of intravesical BCG in the treatment of patients with high risk superficial bladder cancer. International Urology and Nephrology 23, 559–567 (1991). https://doi.org/10.1007/BF02549846

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02549846

Keywords

Search

Navigation